TRIPHASE

Triphase focuses on accelerating oncology products from pre-investigational new drug (pre-IND) to POC in less time with less capital than traditional pharma and biotech approaches. It accomplishes this with a lean semi-virtual operating model through support from world-class scientists, clinicians, collaboration partners, and entrepreneurial resources predominantly in Canada and the United States... Triphase Accelerator acquires promising cancer therapies and accelerates their development from pre-IND to clinical proof-of-concept and beyond leveraging our deep relationships with world-class scientists, clinicians and business professionals with access to state-of-the-art facilities and capabilities.

Primary location: La Jolla United States